Viewing StudyNCT00006215



Ignite Creation Date: 2024-05-05 @ 10:17 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006215
Status: UNKNOWN
Last Update Posted: 2013-12-19
First Post: 2000-09-11

Brief Title: Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor: Amgen
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Lung Cancer
Keywords:
Name View
stage IV non-small cell lung cancer View
stage IIIB non-small cell lung cancer View